Home>Topics>Companies>St. Jude Medical

St. Jude Medical STJ

  1. All
  2. Commentary
  3. Headlines
    1. Boston Scientific Sees Decent 1Q, and Our Fair Value Estimate Remains Constant


      Wed, 29 Apr 2015

      shifts in transcatheter aortic valves have been relatively muted, and we think it may be challenging for Boston (and St . Jude Medical ) to chip away at Medtronic's and Edwards' positions in this category. We were heartened to see Boston is close

    2. St . Jude Medical Posts Solid 1Q; New Technologies Hold Attractive Prospects for Growth


      Wed, 22 Apr 2015

      St . Jude Medical reported solid first-quarter performance ..... and other providers. We stand behind St . Jude 's wide economic moat and stable trend ..... from defibrillators and pacemakers. St . Jude managed to rack up 5% quarterly revenue

    3. Global Ultrasound Equipment market to grow at a CAGR of 5.79% during 2015


      Tue, 24 Feb 2015

      Analogic Boston Scientific Carestream Health Esaote Fujifilm Medical Hitachi Medical Mindray Medical Samsung Medison St . Jude Medical TomTec Imaging Systems Trivitron Healthcare Volcano Zonare Medical Systems GmbH Market Driver Rise in Number of MI

    4. Abbott Shakes off Unfavorable Foreign Exchange With Robust Growth


      Fri, 30 Jan 2015

      acquisition of Topera, Abbott seeks to enter the fast-growing atrial fibrillation ablation market. However, St . Jude Medical , Boston Scientific, and Johnson & Johnson are firmly entrenched in that market and Abbott will be playing catch-up

    5. St . Jude Medical Delivers Solid 4Q; We've Inched Up Our Fair Value Estimate


      Wed, 28 Jan 2015

      headwinds in the fourth quarter, St . Jude Medical reported solid quarterly performance ..... We continue to stand behind St . Jude 's wide economic moat, even ..... product portfolios. We think St . Jude 's focus on meaningful innovation

    6. St . Jude Medical Sees Solid 3Q With More to Come From New Products


      Wed, 15 Oct 2014

      St . Jude Medical 's third-quarter results were largely ..... neuromodulation products, wide-moat St . Jude saw quarterly top-line growth of 3 ..... double-digit growth seen historically, St . Jude has been making steady progress recovering

    7. CR Bard Bolsters Narrow Moat With Technology That Appeals to Hospitals Seeking Efficiencies


      Mon, 25 Aug 2014

      physicians have less influence on brand decisions compared with highly engineered, implantable devices. Unlike St . Jude Medical and Zimmer's devices, Bard's products are generally more vulnerable to pricing pressure. However, Bard's

    8. Edwards Lifesciences Posts Strong 2Q on New Launches; We've Raised Our Fair Value Estimate


      Wed, 30 Jul 2014

      this arena. While we had cautiously anticipated rising competition now that Medtronic has entered the U.S. and St . Jude Medical and Boston Scientific have launched in Europe, Edwards showed its own strength in both markets with its rollout

    9. Boston Scientific Exceeds Our Expectations in the Second Quarter


      Thu, 24 Jul 2014

      S-ICD, Boston racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St . Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston's

    10. St . Jude Delivers Solid 2Q Results


      Wed, 16 Jul 2014

      St . Jude Medical posted solid second-quarter performance ..... estimate in place. We were heartened to see St . Jude 's sales of implantable cardioverter defibrillators ..... recently declined in the low single digits. St . Jude 's recent acquisition of Cardiomems

    « Prev12345Next »
    Content Partners